FDA Inspection 885302 — Jacek C. Szepietowski
The FDA completed an inspection of Jacek C. Szepietowski on May 8, 2014 in Wroclaw. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 8, 2014
- Fiscal Year
- 2014
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Wroclaw (Poland)
Additional Details
Clinical Investigator (CI)